Skip to main content

Table 2 Univariate comparison of Factors between patients alive and dead at 10 years

From: Analysis of factors predicting mortality of new patients commencing renal replacement therapy 10 years of follow-up

Factor

Alive at 10 years

Dead at 10 years

P-value

Statistic

Age (years) a

53.2 (15.3)

69.0 (12.4)

<0.001

t(92) = 5.494

Vascular disease – no (%)b

25 (52%)

23 (48%)

  

Vascular disease – yes (%)b

13 (28%)

33 (72%)

0.019

X 2(1) = 5.535

Diabetes – no (%)b

29 (48%)

31 (52%)

  

Diabetes – yes (%)b

9 (27%)

25 (73%)

0.038

X 2(1) = 4.307

Co-morbidity (>3) –no (%)b

31 (60%)

21 (40%)

  

Co-morbidity (>3) – yes (%)b

6 (15%)

35 (85%)

<0.001

X 2(1) = 20..085

Haemoglobin >110 g/l (%)b

5 (50%)

5 (50%)

0.514

X 2(1) = 0.426

Haemoglobin <110 g/l (%)b

33 (39%)

51 (61%)

  

Creatinine at referral (μmol/l) a

483.8 (± 77.9)

411.1 (± 28.6)

0.321

t(92) = 0.999

eGFR at referral (ml/min/1.73 m2) a

18.6 (± 2.8)

19.3 (± 1.8)

0.838

t(92) = 0.205

Creatinine at start of RRT (μmol/l) a

903.6 (± 59.9)

757.8 (± 27.3)

0.016

t(92) = 2.455

eGFR at start of RRT (ml/min/1.73 m2)

6.35 (± 0.4)

6.35 (± 0.2)

0.988

t(92) = 0.015

Albumin at start of RRT (g/L) a

32.0 (± 4.9)

28.6 (± 5.7)

0.004

t(92) = 2.946

Haemoglobin at start of RRT (g/l) a

95.6 (± 2.8)

87.8 (± 2.2)

0.026

t(92) = 2.264

Cholesterol at start of RRT (mmol/l) a

5.2 (± 0.21)

5.0 (± 0.2)

0.685

t(92) = 0.406

Triglycerides at start of RRT (μmol/l) a

2.12 (± 0.22)

2.19 (± 0.16)

0.821

t(92) = 0.227

Calcium phosphate product at start of RRT (mmol2/l2) a

4.84 (± 0.29)

4.44 (± 0.22)

0.262

t(92) = 1.129

  1. a Age: analysis using T-test.
  2. b Chi-squared test.